Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F-C Bidard

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Journal of Clinical Pathology|November 27, 2007
Bone marrow micrometastasis in breast cancer: review of detection methods, prognostic impact and biological issuesA Vincent-Salomon, F C Bidard, J Y Pierga
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 23, 2018
[Circulating tumour DNA: Current detection methods, use in radiotherapy and future development]J Castelli, L Cabel, F-C Bidard, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 11, 2017
Circulating tumor cells and circulating tumor DNA: What surgical oncologists need to know?L Cabel, C Proudhon, P Mariani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 24, 2009
Single circulating tumor cell detection and overall survival in nonmetastatic breast cancerF-C Bidard, C Mathiot, S Delaloge, et al.
ESMO Open|June 18, 2025
Blood tumor load: combining biomarkers to increase the proportion of informative patientsE Dathathri, A Nanou, F-C Bidard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 8, 2008
p53 status and efficacy of primary anthracyclines/alkylating agent-based regimen according to breast cancer molecular classesF-C Bidard, M-C Matthieu, P Chollet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 2010
Survival of breast cancer patients with meningeal carcinomatosisH Gauthier, M N Guilhaume, F C Bidard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 7, 2011
High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patientsJ-Y Pierga, D Hajage, T Bachelot, et al.
Journal of Thrombosis and Haemostasis : JTH|August 6, 2017
Circulating tumor cell count and thrombosis in metastatic breast cancerG Beinse, F Berger, P Cottu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 12, 2008
Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cellsF-C Bidard, A Vincent-Salomon, B Sigal-Zafrani, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Journal of Clinical Pathology|November 27, 2007
Bone marrow micrometastasis in breast cancer: review of detection methods, prognostic impact and biological issuesA Vincent-Salomon, F C Bidard, J Y Pierga
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 23, 2018
[Circulating tumour DNA: Current detection methods, use in radiotherapy and future development]J Castelli, L Cabel, F-C Bidard, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 11, 2017
Circulating tumor cells and circulating tumor DNA: What surgical oncologists need to know?L Cabel, C Proudhon, P Mariani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 24, 2009
Single circulating tumor cell detection and overall survival in nonmetastatic breast cancerF-C Bidard, C Mathiot, S Delaloge, et al.
ESMO Open|June 18, 2025
Blood tumor load: combining biomarkers to increase the proportion of informative patientsE Dathathri, A Nanou, F-C Bidard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 8, 2008
p53 status and efficacy of primary anthracyclines/alkylating agent-based regimen according to breast cancer molecular classesF-C Bidard, M-C Matthieu, P Chollet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 2010
Survival of breast cancer patients with meningeal carcinomatosisH Gauthier, M N Guilhaume, F C Bidard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 7, 2011
High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patientsJ-Y Pierga, D Hajage, T Bachelot, et al.
Journal of Thrombosis and Haemostasis : JTH|August 6, 2017
Circulating tumor cell count and thrombosis in metastatic breast cancerG Beinse, F Berger, P Cottu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 12, 2008
Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cellsF-C Bidard, A Vincent-Salomon, B Sigal-Zafrani, et al.
Pageof 5